Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study

Detalles Bibliográficos
Autores principales: Locatelli, Franco, Zugmaier, Gerhard, Mergen, Noemi, Bader, Peter, Jeha, Sima, Schlegel, Paul-Gerhardt, Bourquin, Jean-Pierre, Handgretinger, Rupert, Brethon, Benoit, Rossig, Claudia, Chen-Santel, Christiane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381625/
https://www.ncbi.nlm.nih.gov/pubmed/32709851
http://dx.doi.org/10.1038/s41408-020-00342-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381625/
https://www.ncbi.nlm.nih.gov/pubmed/32709851
http://dx.doi.org/10.1038/s41408-020-00342-x

Ejemplares similares